Cheng Quah is an accomplished medical professional with over 13 years of experience in oncology drug development, spanning all phases from IND submissions to successful Phase III filings. A graduate of the University of Sydney, he has a proven track record of leading teams and trial design for solid and liquid tumors.
He is a listed inventor on patent applications for novel BTK (Brutons tyrosine kinase) inhibitors from his time at Acerta Pharma.
Read the full overview →Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.